z-logo
open-access-imgOpen Access
Miejsce ruksolitynibu w leczeniu chorych na mielofibrozę
Author(s) -
Aleksandra Gołoś,
Joanna GóraTybor
Publication year - 2018
Publication title -
hematologia
Language(s) - Polish
Resource type - Journals
SCImago Journal Rank - 0.136
H-Index - 5
eISSN - 2081-3287
pISSN - 2081-0768
DOI - 10.5603/hem.2018.0011
Subject(s) - ruxolitinib , myelofibrosis , medicine , constitutional symptoms , immunosuppression , adverse effect , anemia , spleen , extramedullary hematopoiesis , gastroenterology , haematopoiesis , bone marrow , stem cell , disease , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom